JAVELIN Recognition: Insights from One of the Most Cited Papers of the Year

Posted by Matthew Wiens, M.A. on Jun 5, 2024 10:36:10 AM

I am excited to share that one of our recent papers written in collaboration with EMD Serono, Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab, has been recognized as one of the most cited in its publication last year. Reflecting on this achievement, I wanted to provide some insights into why I believe this paper resonated so strongly with the pharmacometrics community and became such a valuable resource.

Read More

Topics: Methodology, Tools, and Computation, Machine Learning, AI

We love to share!

Please take advantage of the content we provide here. Our goal is to help, encourge, and inspire you in your own work! If you have suggestions for blog topics, or would like to co-author a blog post with us, let us know!

Subscribe to Email Updates

Recent Posts